-+ 0.00%
-+ 0.00%
-+ 0.00%

Daxor wins US patent for remote blood volume monitoring technology

PUBT·09/01/2026 12:03:28
Listen to the news
Daxor wins US patent for remote blood volume monitoring technology
  • Daxor received U.S. Patent No. 12,635,917 B2 on June 2, 2026 for a “Remote Blood Volume Monitor.”
  • The patent covers continuous, wearable-sensor monitoring tied to a baseline blood volume analysis measurement to flag clinically meaningful volume shifts.
  • Management framed the IP as extending beyond point-of-care testing into chronic disease management, including heart failure, syncope, anemia.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Daxor Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609010800PRIMZONEFULLFEED9819269) on September 01, 2026, and is solely responsible for the information contained therein.